
Lung cancer pill shows ‘earth-shattering’ results in 5-year study: ‘An optimistic time’
Fox News
Many lung cancer patients now have access to a potentially life-saving new medication called Tagrisso. A surgeon from Hackensack Meridian and a patient share their experiences with the drug.
Among those patients, Tagrisso was shown to reduce the five-year risk of recurrent cancer by up to 73% and the risk of death by up to 51%, according to research published in The New England Journal of Medicine over the summer. "We used to think of lung cancer as just a smoker's illness. Now, we know that over 30% of individuals who develop lung cancer have never smoked." "I absolutely believe that this medication is going to make sure the lung cancer will not return. I am planning on living for many more years." "We are now in an era where in a vast majority of cases, we can either turn it into a chronic disease or aim for a complete cure." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
"In the world of oncology, that is earth-shattering," Dr. Faiz Y. Bhora, chief of thoracic surgery and central region chair of surgery at Hackensack Meridian Health in New Jersey, told Fox News Digital.

'Hydration boosters' or just water? Medical experts make recommendations for beating the summer heat
Medical experts share insights on whether hydration multipliers and electrolyte supplements are needed for staying hydrated in the summer heat, or if water is sufficient.